Cheryl Guttman Krader, BS, Pharm




Study results link frequent anti-VEGF injections, risk of cognitive impairment

Interim data from a cross-sectional study raise concerns that repeated intravitreal injections of an anti-VEGF agent may be associated with a decline in cognitive health.

Abundance of studies explore pharmacotherapy for cataract

Interest stems from the recognition that the number of people affected with cataracts is expected to increase in association with population aging while access to cataract surgery is limited in areas throughout the world.

Preventing post-cataract surgery endophthalmitis

Findings from large retrospective study support intraoperative cefuroxime irrigation

Novel dexamethasone formulation shows efficacy and safety with once-daily use

September 01, 2020

A vehicle-controlled phase 2 study investigating once- and twice-daily administration of a novel, preservative-free topical formulation of dexamethasone as treatment for pain and inflammation after cataract surgery met its primary endpoints.